Notícias e Atividades da Zuellig Pharma

A Zuellig Pharma pertence à Zuellig Group. Zuellig Group tem presença direta em 3 países.

Zuellig Group possui 4 subsidiárias incluindo Green Cross Health, Pharma Industries e Zuellig Pharma.

Eles estão dentro:

• Farmacêutica60%
• Conglomerados industriais20%
• Outro20%

Veja o organograma con seus 16 executivos principais

Biografias mais buscadas da Zuellig Pharma

• John Graham, Chief Executive Officer
• Giuseppe Leo, Senior Vice President, Clinical Trial Support
• Victoria Herrero, Chief People and Sustainability Officer

Criar um alerta
para seguir os movimentos de executivos da Zuellig Pharma.

Zuellig Group possui 1.913 concorrentes concorrentes Sanofi (França), Eli Lilly (Estados Unidos) e Moderna (Estados Unidos).

Popular M&A news in Farmacêutica

• Contraline acaba de anunciar uma arrecadação de fundos de 93 milhões de dólares. (publicado em 3 de junho de 2026).
• Hims & Hers adquiriu Eucalyptus (publicado em 2 de junho de 2026).
• Apotex preencheu seu dossiê de IPO. Seu símbolo de ação será TSX. (publicado em 2 de junho de 2026).

Outros contatos sugeridos na indústria do Farmacêutica

• Joaquin Duato - Chief Executive Officer and Chairman of the Board da Johnson & Johnson
• Richard Saynor - Chief Executive Officer da Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board da Abbott

Saiba mais sobre a indústria do Farmacêutica

Últimos comunicados de imprensa de Zuellig Pharma

• Zuellig Pharma Reinforces Commitment to Japan through Its New Misato Depot, Advancing Clinical Logistics and Sourcing Excellence
• Zuellig Pharma Acquires Cialis® (Tadalafil) from Lilly in three additional markets in Asia
• Zuellig Pharma Strengthens Consumer Healthcare Portfolio with the Acquisition of Zam-Buk® and Vapex® Brands from Bayer
• Zuellig Pharma expands partnership with Lundbeck to support commercialization of neuro-psychiatric health solutions in Asia
• Zuellig Pharma unveils state-of-the-art Clinical Trial Support Innovation Center in South Korea to support both domestic and global clinical research needs
• Zuellig Pharma and Organon Partner to Expand Access to Women’s Health Solutions in Myanmar
• Zuellig Pharma Launches Lilly’s Innovative Obesity and Diabetes Medicine in Thailand
• Tackling Affordability and Access to Healthcare in an Ever-Evolving World
• Zuellig Pharma acquires Propan from ADP Pharma Corporation in the Philippines
• Prioritising Patient Safety with Effective Digital Healthcare Management
• View more press releases Close

Redes sociais sobre Zuellig Pharma

• Zuellig Pharma na Wikipedia, Google News e Yahoo Finance
• Zuellig Pharma na LinkedIn, X (Twitter) e YouTube